) determines whether NSCs enter G 0 or G 2 quiescence during embryogenesis. We demonstrate that the dorsal patterning factor, Muscle segment homeobox (Msh; ortholog of MSX1/2/3) binds directly to the Dap locus and induces Dap expression in dorsal NSCs, resulting in G 0 arrest, while more ventral NSCs undergo G 2 quiescence. Our results reveal region-specific regulation of stem cell quiescence.
INTRODUCTION
Neural stem cells (NSCs) are located in two main regions of the adult mammalian brain, the dentate gyrus of the hippocampus and the ventricular-subventricular zone (V-SVZ) of the lateral ventricles (Doetsch et al., 1999; Seri et al., 2001) . These NSCs reside primarily in a mitotically dormant state known as quiescence. Stimuli including injury and exercise can induce quiescent NSCs to divide and produce new neurons or glia (LlorensBobadilla et al., 2015; Lugert et al., 2010) . By characterizing quiescence regulators, it may become possible to activate quiescent NSCs on demand and regenerate brain tissue following injury or disease (Encinas and Fitzsimons, 2017) .
Quiescent NSCs vary in their sensitivities or responses to external stimuli, suggesting that they undergo different types of quiescence. For example, ''resting'' stem cells in the adult mouse hippocampus, which are quiescent NSCs that have proliferated recently, are more likely to become activated than naive quiescent NSCs (Urbá n et al., 2016) . Quiescent progenitors are also differentially responsive to norepinephrine and KCl (Jhaveri et al., 2015) . Once activated, quiescent NSCs in the brain generate different types of progeny in a region-specific manner (Fuentealba et al., 2015) . Single-cell profiling has revealed transcriptional and metabolic heterogeneity in quiescent NSCs, linked to priming for activation and regional identity (Dulken et al., 2017; Llorens-Bobadilla et al., 2015; Shin et al., 2015) . Although it is now appreciated that quiescent NSCs exhibit significant heterogeneity (Chaker et al., 2016) , the factors that induce stem cells to undergo different types of quiescence in the brain are not understood well.
It has been widely accepted for many years that quiescent stem cells arrest in G 0 of the cell cycle (Cheung and Rando, 2013) . However, we discovered recently that NSCs in the Drosophila melanogaster central nervous system undergo two distinct types of quiescence: 75% of NSCs arrest in G 2 of the cell cycle and only 25% arrest in G 0 (Otsuki and Brand, 2018) . G 2 -quiescent NSCs activate rapidly in response to a nutritional stimulus, while G 0 -quiescent NSCs respond more slowly (Figure 1A) (Otsuki and Brand, 2018) . Thus, G 2 and G 0 NSCs are functionally distinct types of quiescent stem cell. We showed that NSCs are pre-programmed to undergo G 0 or G 2 quiescence in an invariant manner (Otsuki and Brand, 2018 ). An understanding of the differential regulation of G 0 /G 2 quiescence should reveal the factors that trigger different types of stem cell quiescence.
Here, we demonstrate that the cyclin-dependent kinase inhibitor p57/Dap directs NSCs to enter G 0 quiescence, rather than G 2 quiescence, during embryogenesis. Upon loss of p57/dap, NSCs switch from G 0 to G 2 quiescence and, as a result, reactivate more rapidly in response to nutrition post-embryonically. We found that G 0 NSCs primarily occupy dorsal regions of the central nervous system and that G 2 NSCs primarily occupy ventral regions, suggesting that dorsal-ventral patterning cues might influence p57/dap expression and consequently the choice between G 0 or G 2 stem cell quiescence. We discovered that the dorsal patterning transcription factor Muscle segment homeobox (Msh, also known as Drop/Dr-Flybase) promotes G 0 quiescence by inducing p57/dap expression in a subset of dorsal NSCs. msh and p57/dap are evolutionarily conserved, suggesting that a similar region-specific mechanism might induce different types of stem cell quiescence in the mammalian brain.
RESULTS

Dap Is Necessary for G 0 Quiescence
The factors that regulate the choice between G 0 and G 2 quiescence in NSCs at the end of embryogenesis are not known (Figure 1A) . We hypothesized that p57/Dap regulates G 0 stem cell quiescence, as it is the sole Drosophila ortholog of the evolutionarily conserved p21 CIP /p27 KIP1 /p57 KIP2 family of cyclin-dependent kinase inhibitors capable of blocking G 0 /G 1 >S progression in the cell cycle (de Nooij et al., 1996; Lane et al., 1996) . We assessed quiescent NSCs in the loss-of-function mutant dap 04454 (de Nooij et al., 1996; Spradling et al., 1995) using cyclin A (CycA) expression to distinguish between G 0 (CycA À ) and G 2 (CycA + ) quiescence, as described previously (Otsuki and Brand, 2018) . We focused on the thoracic segments of the ventral nerve cord (tVNC), a region of the central nervous system in which individual NSCs can be identified readily based on spatial position and molecular markers (Lacin and Truman, 2016) . Remarkably, we found that G 0 -quiescent NSCs had almost completely disappeared in dap mutant tVNCs (Figures 1B and 1D) . dap mutants had an average of 0.6 ± 0.1 G 0 NSCs per hemi-segment, compared to 7.2 ± 0.2 G 0 NSCs per hemi-segment in controls (92% reduction, n = 10 tVNCs, 6 hemi-segments each).
The loss of G 0 NSCs might be due to cell death or premature differentiation. However, we found no change in the total num- Figure S1 . ber of NSCs in dap mutants (n = 136 ± 2.7 NSCs versus 136 ± 4.0 NSCs, 10 tVNCs each, p > 0.05, Student's t test). We hypothesized that the G 0 NSCs might instead have switched to G 2 quiescence. To test this, we focused on quiescent NSCs in the ''dorsal triplet,'' a group of three NSCs (NB2-4, NB2-5, and NB3-5) that can be discriminated unambiguously based on their spatial location in the tVNC (Lacin and Truman, 2016) . NB2-4 and NB2-5 in the dorsal triplet normally undergo G 0 quiescence, while NB3-5 arrests in G 2 ( Figure 1C ) (Otsuki and Brand, 2018) . In dap mutant brains, we found that NB2-4 and NB2-5 switched from G 0 quiescence to G 2 quiescence, leading to all dorsal triplet NSCs arresting in G 2 ( Figure 1E ). We observed a similar reduction in G 0 -quiescent NSCs and increase in G 2 -quiescent NSCs when we knocked down dap specifically in NSCs throughout embryogenesis using the worniu (wor)-GAL4 driver ( Figure S1A ) (Albertson et al., 2004) . We conclude that Dap is necessary for G 0 NSC quiescence and that Dap is required autonomously in NSCs.
We showed previously that G 2 NSCs become activated more rapidly than G 0 NSCs in response to nutrition (Otsuki and Brand, 2018 ). Therefore, we tested whether dap knockdown caused ''G 0 '' NSCs to reactivate at the same rate as G 2 NSCs. We assessed NSC activation at 20 h after larval hatching (ALH), a time point when, in control brains, most G 2 NSCs have reactivated but most G 0 NSCs remain quiescent (Otsuki and Brand, 2018) . We found a substantial increase in the number of NSCs that had reactivated by 20 h ALH in dap knockdown brains compared to controls (Figure S1B) . Thus, the switch from G 0 to G 2 quiescence after dap knockdown is sufficient to accelerate the time at which NSCs reactivate.
G 0 NSCs Express Dap Prior to Quiescence Entry
Next, we assessed the timing of Dap expression in NSCs. The levels of Dap oscillate during the cell cycle (Baumgardt et al., 2014) ; therefore, to assess Dap transcription, we used a transcriptional reporter in which lacZ is inserted at the dap locus (hereafter ''dap::lacZ''; Spradling et al., 1999) . Importantly, b-galactosidase is stable, and its abundance is not regulated by the cell cycle. We observed a subset of NSCs expressing dap prior to quiescence entry ( Figure 2A ) and, by co-staining for CycA, found that dap expression is almost entirely specific to G 0 NSCs. 89% of G 0 NSCs (6.4 ± 0.3 out of 7.2 ± 0.3 per hemi-segment) expressed dap::lacZ in contrast to 13% of G 2 NSCs (2.6 ± 0.2 out of 19.7 ± 0.7 per hemi-segment) ( Figure 2B ). Typifying this pattern, the two G 0 NSCs of the dorsal triplet (NB2-4 and NB2-5) expressed dap::lacZ but not the G 2 NSC (NB3-5) ( Figure 2C ).
Once NSCs enter quiescence, we found that they no longer transcribe or translate Dap ( Figures S2A-S2C ). Thus, G 0 NSCs express Dap in the embryo but downregulate its expression concomitant with quiescence entry.
G 0 -and G 2 -Quiescent NSCs Are Distributed in a DorsalVentral Gradient NSCs acquire their identities through spatial patterning in the developing nervous system. Therefore, the decision to undergo G 0 or G 2 quiescence might be influenced by spatial positioning. By comparing the distributions of G 0 and G 2 NSCs in the tVNC, we noticed a bias toward G 0 NSCs in dorsal regions and G 2 NSCs in ventral regions. In contrast, we found no bias along the anterior-posterior axis (Figures 3A and 3B) . This suggested that dorsal-ventral patterning cues might influence dap expression and G 0 quiescence entry.
The dorsal-ventral axis of the tVNC is patterned during embryogenesis by three conserved homeobox transcription fac- tors expressed in adjacent columns of the neuroectoderm: msh (dorsal identity; human orthologs: MSX1/2/3), intermediate neuroblasts defective (ind; intermediate identity; human orthologs: GSX1/2), and ventral nervous system defective (vnd; ventral identity; human orthologs: NKX family) (Chu et al., 1998; D'Alessio and Frasch, 1996; Isshiki et al., 1997; McDonald et al., 1998; Weiss et al., 1998) . When NSCs delaminate from the neuroectoderm, they continue to express either Msh, Ind, or Vnd, depending upon their position along the dorsoventral axis. The only exceptions to this rule are NB3-3, NB3-5, and NB4-4, which delaminate from the Msh + domain but do not themselves express msh (Isshiki et al., 1997 ) ( Figure S3A) . By aligning our G 0 /G 2 quiescence map with the Msh/Ind/Vnd expression domains, we found that 5 of 7 Msh + (dorsal) NSCs per hemi-segment undergo G 0 quiescence, compared to just 1 of 9 Vnd + (ventral) NSCs ( Figures 3C and S3A ). We confirmed that most G 0 NSCs originate in the dorsal Msh + domain by using msh-GAL4 (driven by a $3.5 kb fragment upstream of msh) to express GAL4 technique for real-time and clonal expression (G-TRACE) (Evans et al., 2009) . We found that an average of 4.2 ± 0.1 out of 7.7 ± 0.2 G 0 NSCs per hemi-segment were Msh > G-TRACE + (n = 8 tVNCs, 6 hemi-segments each) (Figure 3D ; compare to 3B). We obtained the same number when we labeled Msh + NSCs using a lacZ insertion at the msh locus The Dorsal Patterning Factor Msh Promotes G 0 Quiescence To test whether Msh promotes G 0 quiescence, we quantified G 0 -versus G 2 -quiescent NSCs in msh mutant brains at embryonic stage 17. We found that only 3.7 ± 0.1 G 0 -quiescent NSCs remained per hemi-segment in msh D68 mutants compared to 6.3 ± 0.3 in controls (41% reduction; n = 10 tVNCs, 6 hemi-segments each) ( Figure S3B ). G 0 NSCs had not died or differentiated in msh mutants, as the total number of NSCs was the same as in controls (n = 136 ± 3.1 NSCs versus 134 ± 6.2 NSCs, p > 0.05, Welch's test). This indicated that a subset of NSCs switches from G 0 to G 2 quiescence in msh mutants, as occurs in dap mutants. As Msh is necessary for dorsal patterning (Isshiki et al., 1997) , we surmised that dorsal (but not ventral) NSCs switch from G 0 to G 2 quiescence in msh mutants. To test this, we focused again on dorsal triplet NSCs, as they are three of the most dorsally located NSCs in the tVNC (Lacin and Truman, 2016) . The two G 0 NSCs in the dorsal triplet (NB2-4 and NB2-5) express msh, whereas the G 2 NSC (NB3-5) does not ( Figure 4A ). In msh mutant brains, we found that NB2-4 and NB2-5 switched from G 0 quiescence to G 2 quiescence, resulting in all three dorsal triplet NSCs becoming quiescent in G 2 (Figure 4B) . Thus, Msh promotes G 0 quiescence in dorsal NSCs. As a comparison, we assessed a G 0 NSC on the ventral side of the tVNC (NB2-2), which never expresses Msh normally. As expected, NB2-2 remained G 0 arrested in msh mutants (Figure S3C) . Thus, Msh promotes G 0 quiescence in dorsal, but not ventral, NSCs.
We tested whether the ventral patterning factor Vnd also has the ability to promote G 0 quiescence in the tVNC. NB2-2 is the only Vnd + NSC per hemi-segment that undergoes G 0 quiescence ( Figure S3A ). In vnd 6 mutants, we found that NB2-2 did not switch from G 0 to G 2 quiescence ( Figures S3D and S3E 0 ). We conclude that Vnd does not promote G 0 quiescence ventrally.
Msh Directly Induces Dap Expression in Dorsal NSCs
Dap and Msh both promote G 0 stem cell quiescence and could act in a linear pathway. We found that the same NSCs (for example, NB2-4 and NB2-5) co-express Msh and Dap during embryogenesis ( Figures 2C and 4A) . We tested whether Msh induces dap expression, as NSCs begin to express msh from embryonic stage 9/10 while dap expression initiates later, from embryonic stage 11 (Baumgardt et al., 2014; de Nooij et al., 1996; Isshiki et al., 1997; Lane et al., 1996) . Consistent with Msh promoting dap expression, we found that dorsal NSCs lost Dap expression in msh mutant embryos ( Figures S4A and  S4B) . Only 2.6 ± 0.3 NSCs per hemi-segment expressed Dap in msh mutant embryos compared to 4.9 ± 0.2 NSCs in controls, a decrease of almost 50% ( Figure 4C ). Thus, Msh is one upstream regulator that promotes Dap expression in the central nervous system.
Msh might promote Dap expression in NSCs directly, by binding to the dap locus and inducing transcription, or indirectly. The genomic targets of Msh are not known. We therefore elucidated the genome-wide binding targets of Msh in NSCs in vivo using Targeted DamID (TaDa) (Marshall and Brand, 2015; Marshall et al., 2016; Southall et al., 2013) . We generated transgenic Drosophila carrying UAST-LT3-NDam-Msh, which we expressed specifically in NSCs in vivo using wor-GAL4. We found that Msh binds directly to the dap locus in NSCs ( Figures 4D  and S4C ). Remarkably, Msh binding at the dap locus precisely matched the enhancer sequences previously shown to be sufficient for dap expression in the embryonic central nervous system (Liu et al., 2002;  Figure 4D ).
We conclude that the dorsal patterning factor Msh binds directly to dap enhancers in dorsal NSCs and induces dap expression. As Dap promotes G 0 quiescence, this leads to a preferential distribution of G 0 -quiescent NSCs in dorsal regions of the brain ( Figure 4E ). In contrast, Msh is not expressed in ventral regions, where more NSCs undergo G 2 quiescence ( Figure 4E ). G 2 -quiescent NSCs become activated first, followed by G 0 -quiescent NSCs, during larval life (Otsuki and Brand, 2018) . Thus, differential dap expression results directly in functional heterogeneity among quiescent stem cells. 
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DISCUSSION
Quiescent NSCs in the mammalian brain exhibit significant heterogeneity in function and molecular profile (Dulken et al., 2017; Llorens-Bobadilla et al., 2015; Shin et al., 2015) . In order to harness quiescent NSCs for regenerative therapies, it will be necessary to identify the regulators that control different types of stem cell quiescence. Here, we have identified Msh-p57/ Dap as one regulatory arc that induces G 0 stem cell quiescence in dorsal NSCs of the central nervous system. Together with our previous finding that the pseudokinase Tribbles (Trbl) regulates G 2 NSCs (Otsuki and Brand, 2018) , we have elucidated the mechanisms that allocate and regulate NSCs entering G 0 or G 2 quiescence. We found that Dap expression (1) initiates in a subset of dividing NSCs during embryogenesis and (2) induces these NSCs to enter G 0 quiescence. These features show remarkable parallels with p57 expression and function in mammalian NSC quiescence. In the developing mouse brain, p57 expression increases in a subset of proliferating embryonic NSCs around (D) Msh binding at the dap locus, assessed specifically in embryonic NSCs using TaDa (Southall et al., 2013) . Unlogged data assembled from three biological replicates. Orange bars indicate enhancers that were characterized functionally to drive dap expression in the central nervous system (Liu et al., 2002 E15.5, inducing them to enter G 0 quiescence (Furutachi et al., 2015) . Once quiescent, p57-expressing NSCs are retained into the adult V-SVZ (Fuentealba et al., 2015; Furutachi et al., 2015) . Intriguingly, p57 deletion in the developing mouse brain was shown to reduce, but not eliminate, the emergence of quiescent NSCs in the adult V-SVZ, suggesting that some NSCs in the mammalian brain do not require p57 for quiescence entry (Furutachi et al., 2015) . We found that $75% of NSCs do not express Dap in the Drosophila brain and that these NSCs later become quiescent in G 2 instead of G 0 . The p57-independent NSCs in the mouse brain might be comparable to G 2 -quiescent NSCs in Drosophila.
In both mammals and Drosophila, NSCs are set aside to become quiescent during proliferative stages. Interestingly, Dap has been shown to induce a switch in NSC proliferation mode during Drosophila embryogenesis (Baumgardt et al., 2014) . At cell division, most NSCs in the brain produce a ganglion mother cell (GMC) that divides once to generate two neurons and/or glia (type 1 proliferation). During mid-embryogenesis, Dap-expressing NSCs switch from type 1 proliferation to type 0 proliferation, in which the GMC differentiates directly into a post-mitotic cell without dividing (Baumgardt et al., 2009 (Baumgardt et al., , 2014 Karcavich and Doe, 2005) . It has been suggested that all NSCs express Dap during embryogenesis (Baumgardt et al., 2014) . We now show that only a subset of embryonic NSCs, the G 0 population, expresses Dap. We propose that Dap-expressing NSCs first switch from type 1 to type 0 proliferation at mid-embryogenesis, before undergoing G 0 quiescence (Figure 4E) . In contrast, Dap non-expressing NSCs remain in type 1 proliferation mode and undergo G 2 quiescence ( Figure 4E) . A similar switch in NSC proliferation mode may also precede quiescence entry in the developing mammalian brain.
We have shown that the dorsal patterning factor Msh directly induces Dap expression in dorsal NSCs, causing them to enter G 0 quiescence. The switch from G 0 to G 2 quiescence in msh mutants is less severe than in dap mutants, suggesting that Msh is one of the several regulators upstream of Dap expression. Indeed, Hox genes, Notch signaling, and temporal patterning factors have been shown to influence Dap expression in the brain (Baumgardt et al., 2014; Bivik et al., 2016; Monedero Cobeta et al., 2017; Gunnar et al., 2016) .
The distribution of G 0 -versus G 2 -quiescent NSCs along the dorsal-ventral brain axis is striking, given that G 2 -quiescent NSCs reactivate to produce neurons faster than G 0 NSCs (Otsuki and Brand, 2018) . It is possible that ventral neurons must be generated first to direct dorsal neurons to form the correct neural circuits, in a role comparable to the pioneer neurons of the embryonic nervous system (Jacobs and Goodman, 1989) . The dorsal-ventral patterning system is well conserved evolutionarily, and the homologs of Msh, Ind, and Vnd are also expressed in columns during mammalian brain development (Urbach and Technau, 2008) . It is not known whether dorsal-ventral patterning controls p57 expression in NSCs in the mammalian brain. However, MSX1, one of the Msh homologs, binds upstream of the p57 locus in cultured mouse myoblasts (Wang et al., 2011) . Our finding that Msh directly induces dap expression in NSCs raises the possibility that dorsal-ventral control of p57/Dap and NSC quiescence is conserved in the mammalian brain.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Drosophila melanogaster Rearing and Genetics Drosophila melanogaster were reared at 25 C except for RNAi experiments, which were conducted at 29 C. Embryos were collected onto yeasted apple juice plates and staged according to (Campos-Ortega and Hartenstein, 1985) . For larval experiments, larvae were transferred to a fresh, yeasted food plate within one hour of hatching (designated 0 hours after larval hatching (ALH)) and allowed to develop to the required stage. The following stocks were obtained from the Bloomington Drosophila Stock Centre: w 1118 , dap 04454 (BL11377) (de Nooij et al., 1996; Spradling et al., 1995) , dap Df9016 (BL7867), dap k07309 (dap::lacZ; BL10406) (Spradling et al., 1999) , wor-GAL4 (Albertson et al., 2004) , P{TRiP.HMS05362}attP40 (dap RNAi; BL64026), P{GMR19B03-GAL4}attP2 (msh-GAL4; BL49830), G-TRACE (BL28280) (Evans et al., 2009 ), P{VALIUM20-mCherry}attP2 (mCherry RNAi; BL35785). The following stocks were obtained from the Kyoto Drosophila Stock Centre: msh D68 (116970) (Isshiki et al., 1997) , msh lacZ-D89 (msh::lacZ; 116971) (Isshiki et al., 1997) . vnd 6 was a kind gift from Fernando Jimé nez Díaz-Benjumea (Centro de Biología Molecular Severo Ochoa, Spain) (Jimé nez et al., 1995) . UAST-LT3-NDam was published previously (Southall et al., 2013) . The following stock was generated for this study: UAST-LT3-NDam-Msh.
METHOD DETAILS Antibody Staining
Embryos were washed into a nitex basket with water, dechorionated for 3 minutes in 50% bleach/water, then fixed for 20 minutes in 4% formaldehyde (in PBS)/heptane on a rolling shaker. Fixed embryos were stored in methanol at -20 C until use. For immunostaining: fixed embryos were re-hydrated in PBTx (0.3% Triton X-100/PBS), blocked for 15 minutes in 10% normal goat serum/PBTx, then incubated overnight with primary antibodies at 4 C. Primary antibodies were washed off with PBTx and replaced with secondary antibodies for 2 hours at room temperature, or overnight at 4 C. Secondary antibodies were washed off with PBTx and embryos were mounted in 50% glycerol/PBS.
Larval brains were dissected in PBS, then fixed for 20 minutes in 4% formaldehyde/PBS. Fixed brains were washed three times in PBTx, blocked for 15 minutes in 10% normal goat serum/PBTx, then immunostained as described for embryos. Larval brains were mounted in Vectashield mounting medium (Vector Laboratories).
The following primary antisera were used, diluted in PBTx: chicken anti-bgal 1:1,000 (abcam, ab9361), rabbit anti-CycA 1:500 ( (Whitfield et al., 1990) , rb270), rabbit anti-Dap 1:600 (gift from C. Lehner), guinea pig anti-Dpn 1:5,000 (Caygill and Brand, 2017) , rat anti-Dpn 1:100 (abcam, 11D1BC7, ab195173), guinea pig anti-Run 1:200 (Kosman et al., 1998, 638) , rat anti-Wor 1:100 (abcam, 5A3AD2, ab196362). Primary antibodies were detected using Alexa Fluor-conjugated secondary antibodies (Thermo Fisher Scientific) diluted 1:500 in PBTx.
Designation of 'Dorsal' and 'Ventral' in Confocal Microscopy Images tVNCs were imaged in ventral view. The left-right axis in each image corresponds to medial-lateral in the tVNC. During Drosophila embryogenesis, ventral NSCs delaminate medially and dorsal NSCs delaminate laterally. Thus, the medial-lateral axis is labelled dorsal-ventral in confocal images.
dap Mutant Analysis
The loss of function allele dap 04454 was crossed to the genomic deficiency dap Df9016 and designated 'dap mutant' throughout this study, as described in (Baumgardt et al., 2014) .
dap Knockdown in NSCs dap RNAi was expressed in NSCs using wor-GAL4. Flies were raised at 29 C and assessed at 0ALH. To assess stem cell activation, dap RNAi (or control) larvae were transferred within 1 hour ALH to a new food plate and kept for a further 20 hours at 25 C. Brains were dissected at 20ALH, and co-stained for Dpn (to label NSCs) and Wor (to label activated NSCs).
msh>G-TRACE G-TRACE was expressed in Msh-expressing NSCs using GMR19B03-GAL4. Flies were raised at 25 C and assessed at 0ALH. The image in Figure 3D depicts the 'historical expression' reporter from the G-TRACE cassette. The amplified PCR product was digested with XhoI and XbaI enzymes and ligated into pUASTattB-LT3-NDam (Southall et al., 2013) , also digested with XhoI and XbaI, to generate pUASTattB-LT3-NDam-Msh.
Generation of UASTattB-LT3-NDam-Msh Flies for TaDa
Stable transgenic flies (UAST-LT3-NDam-Msh) were established by injecting pUASTattB-LT3-NDam-Msh into embryos expressing phiC31 integrase and carrying the attP2 genomic landing site on III. Successful transgenesis was confirmed by sequencing.
Identification of Msh Genome-Wide Binding Targets Using TaDa Msh targets were identified using TaDa (Southall et al., 2013) . wor-GAL4 flies were crossed to control (UAST-LT3-NDam) or test (UAST-LT3-NDam-Msh) flies. Embryos were collected onto apple juice plates for a two-hour period and developed at 25 C for 20 hours. Embryos were washed into a nitex basket using distilled water and dechorionated by swirling for three minutes in 50% bleach. Dechorionated embryos were washed well with distilled water, transferred to an Eppendorf tube, liquid removed and frozen at -80 C until ready for use. Three replicate experiments were conducted and $25ml of embryos were used for each replicate. Genomic DNA was extracted from embryos using the QiaAmp DNA micro kit (Qiagen), as described previously in the TaDa protocol (Marshall et al., 2016) . In brief, frozen embryos were re-suspended in PBS containing 110mM EDTA and 0.25mg of RNase A, then disrupted mechanically using an electric drill. 20ml of Proteinase K (QiaAmp DNA micro kit) were added, and the sample left for 1 minute at room temperature. 200ml of Buffer AL were added, the tube was inverted gently to mix and then incubated at 56 C overnight. The following day, the sample was cooled to room temperature and 200ml of 100% ethanol added. The sample was applied to a QiaAmp DNA micro kit spin column, then washed and centrifuged on the column with AW1 followed by AW2 solution. The column was transferred to a clean tube and centrifuged again to dry. Finally, the column was transferred to a clean tube and the genomic DNA eluted in 50ml of AE buffer. Genomic DNA was digested with DpnI enzyme (NEB) overnight at 37 C, ligated with DamID adaptors, then digested with DpnII enzyme. Adapted DNA was PCR amplified, sonicated and prepared for Illumina sequencing. TaDa sequencing data were aligned to Drosophila genome annotation release 6.
Image Acquisition and Processing
Fluorescent images were acquired using a Leica SP8 confocal microscope. Images were analysed using Fiji software (Schindelin et al., 2012) . Images were processed for brightness and contrast using Adobe Photoshop. Msh binding data were visualised using Integrative Genomics Viewer (IGV) software (Robinson et al., 2011) . Figures were compiled in Adobe Illustrator.
QUANTIFICATION AND STATISTICAL ANALYSIS
NSCs in the tVNC of the Drosophila central nervous system were quantified throughout this study. Quantifications in the form 'NSCs per hemi-segment' are average values calculated by dividing the total number of NSCs in the tVNC by six (the number of hemi-segments in the tVNC). R was used for statistical analysis. Data were tested for assumptions of normality (Shapiro-Wilk test) and equality of variance (Levene's test). Statistical tests can be found in the relevant figure legends. Statistical significance was defined as p<0.05. No data were excluded.
